Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2026-02-25 @ 8:17 PM
Study NCT ID:
NCT00511095
Status:
COMPLETED
Last Update Posted:
2019-04-30
First Post:
2007-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine
Sponsor:
Dynavax Technologies Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DV2-HBV-14
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None